Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): A Randomized Double-Blind Non-Inferiority Trial

Yong-Seok Lee,Hee-Joon Bae,Dong-Wha Kang,Seung-Hoon Lee,Kyung-Ho Yu,Jong-Moo Park,Yong-Jin Cho,Keun-Sik Hong,Dong-Eog Kim,Sun Uck Kwon,Kyung Bok Lee,Joung-Ho Rha,Jaseong Koo,Moon-Gu Han,Soo Joo Lee,Ju-Hun Lee,Sang Wook Jung,Byung-Chul Lee,Jong S. Kim

Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): A Randomized Double-Blind Non-Inferiority Trial

2011

Yong-Seok Lee
Hee-Joon Bae
Dong-Wha Kang
Seung-Hoon Lee
Kyung-Ho Yu
Jong-Moo Park
Yong-Jin Cho
Keun-Sik Hong
Dong-Eog Kim
Sun Uck Kwon
Kyung Bok Lee
Joung-Ho Rha
Jaseong Koo
Moon-Gu Han
Soo Joo Lee
Ju-Hun Lee
Sang Wook Jung
Byung-Chul Lee
Jong S. Kim

Background: Aspirin is a proven antiplatelet agent in acute ischemic stroke, and there are no current guidelines for other antiplatelet treatments. We aimed to compare the efficacy

Keywords:

Randomized controlled trial
Cilostazol
Cardiology
Internal medicine
Modified Rankin Scale
Physical therapy
Stroke
Aspirin
Medicine
Adverse effect
ischemic stroke
Diabetes mellitus
non inferiority trial
double blind
acute ischemic stroke

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations